celastrol has been researched along with Pancreatitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SY; He, XH; Hu, B; Li, YP; Liang, QQ; Ouyang, DY; Shi, ZJ; Xu, LH; Xu, R; You, YP; Yuan, T; Zha, QB; Zhang, HR | 1 |
| Cao, X; Deng, L; Tu, H; Zhang, ZR; Zhou, X | 1 |
| Du, Z; Fu, Y; Hu, X; Li, P; Li, S; Luo, S; Zhang, Z | 1 |
3 other study(ies) available for celastrol and Pancreatitis
| Article | Year |
|---|---|
Celastrol inhibits necroptosis by attenuating the RIPK1/RIPK3/MLKL pathway and confers protection against acute pancreatitis in mice.
Topics: Acute Disease; Animals; Apoptosis; Caspases; Ceruletide; Mice; Necroptosis; Pancreatitis; Pentacyclic Triterpenes; Protein Kinases; Receptor-Interacting Protein Serine-Threonine Kinases | 2023 |
Inflammation-Targeted Delivery of Celastrol via Neutrophil Membrane-Coated Nanoparticles in the Management of Acute Pancreatitis.
Topics: Amylases; Animals; Cell Membrane; Disease Models, Animal; Inflammation; Interleukin-6; Lung Injury; Male; Molecular Targeted Therapy; Nanoparticles; Neutrophils; Pancreatitis; Particle Size; Pentacyclic Triterpenes; Pharmaceutical Vehicles; Polyesters; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Tissue Distribution; Treatment Outcome; Triterpenes; Tumor Necrosis Factor-alpha | 2019 |
N,N-Dimethyl Tertiary Amino Group Mediated Dual Pancreas- and Lung-Targeting Therapy against Acute Pancreatitis.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Hep G2 Cells; Humans; Lung; Male; Pancreas; Pancreatitis; Pentacyclic Triterpenes; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Taurocholic Acid; Triterpenes | 2017 |